Pharmaceutical Isolators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,995	279 Pages	Fairfield Market Research	January, 2024	FCSL18414297

Best Price Guarantee
Price	from $4,995
Length	279 Pages
Publisher	Fairfield Market Research
Published Date	January, 2024
SKU	FCSL18414297

Pharmaceutical Isolators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global pharmaceutical isolators market has witnessed substantial growth, reaching a value of US$ 620 million in 2024, and is projected to reach US$ 925 million by the end of 2031.

Market Overview

Pharmaceutical isolators are pivotal in the healthcare sector, offering safety and efficiency in pharmaceutical and biotech operations. These devices are designed to meet the rigorous requirements of manufacturing and research facilities, fostering market growth. Their low operating costs make them an attractive choice for pharmaceutical companies, providing a cost-effective alternative to traditional clean rooms.

Opportunities for Suppliers
• Low Operating Costs and Biopharma Industry Growth: Pharmaceutical isolators offer a cost-effective solution for healthcare facilities, allowing pharmaceutical companies to acquire them at a fraction of the cost of conventional clean rooms. These isolators reduce contamination risks, ensuring a bio-decontaminated environment for production materials and medicines. Additionally, the expanding biotechnology industry has been a driving force, with both large and small biotech firms driving research and development efforts.
• Technological Advancements: Ongoing innovations in pharmaceutical isolators, including enhanced mobility, compatibility with active pharmaceutical ingredients (APIs), and robust sterility guarantees, will contribute to market growth.

Challenges Faced by the Market
• High Installation Costs and Limited RABS Adoption: While pharmaceutical isolators offer superior qualities, their high installation and maintenance costs may hinder market expansion. Additionally, limited adoption of restricted access barrier systems (RABS) in healthcare manufacturing systems, which require more extensive operating areas, presents challenges to the market.

Country-wise Insights

U.S. Market Dominance: The U.S. leads the North American pharmaceutical isolators market and is expected to maintain this position throughout the forecast period. The country's robust pharmaceutical industry, coupled with research in gene therapies and vaccine development, contributes to its market share.

Germany's Emerging Role: Germany is poised to emerge as a significant player in the pharmaceutical isolators market due to the presence of established manufacturers and its position as a key producer of aseptic processing equipment.

Japan's Outlook: Japan's market revenue is driven by productivity improvements linked to its population and workforce. The introduction of international standards for isolator systems enhances pharmaceutical manufacturing processes and quality.

Competitive Analysis

The pharmaceutical isolators market is highly fragmented, with numerous competitors. To meet customer demand and expand their reach, companies are employing various strategies, including collaborations, manufacturing expansion, and participation in industry events to showcase innovations.

Key Companies Profiled
• Skan AG
• COMECER S.p.A
• Hosokawa Micron Ltd
• Getinge AB
• Azbil Telstar
• Robert Bosch GmbH
• Klenzaids
• Nuaire
• Iso Tech Design
• M. BRAUN INERTGAS-SYSTEME GMBH
• I.M.A. SpA
• Syntegon Technologies GmbH
• Esco Micro Pte. Ltd.

Key Segments of Pharmaceutical Isolators Industry Research

Pharmaceutical Isolators Market by Product:
• Open Isolators
• Closed Isolators

Pharmaceutical Isolators Market by End-User:
• Biotech & Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals
• Contract Research Organizations

Pharmaceutical Isolators Market by Region:
• North America Pharmaceutical Isolators Market
• Latin America Pharmaceutical Isolators Market
• Europe Pharmaceutical Isolators Market
• East Asia Pharmaceutical Isolators Market
• South Asia Pharmaceutical Isolators Market
• Oceania Pharmaceutical Isolators Market
• Middle East and Africa (MEA) Pharmaceutical Isolators Market

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.

1. Executive Summary: 1.1. Global Molecular Diagnostics in Infectious Disease Testing Market Snapshot; 1.2. Future Projections; 1.3. Key Market Trends; 1.4. Regional Snapshot, by Value and Volume, 2023; 1.5. Analyst Recommendations
2. Market Overview: 2.1. Market Definitions and Segmentations; 2.2. Market Dynamics; 2.2.1. Drivers; 2.2.2. Restraints; 2.2.3. Market Opportunities; 2.3. Value Chain Analysis; 2.4. Porter’s Five Forces Analysis; 2.5. COVID-19 Impact Analysis; 2.5.1. Supply; 2.5.2. Demand; 2.6. Impact of Ukraine-Russia Conflict; 2.7. Economic Overview; 2.7.1. World Economic Projections; 2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 – 2023: 3.1. Global Molecular Diagnostics in Infectious Disease Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 – 2023; 3.1.1. North America; 3.1.2. Europe; 3.1.3. Asia Pacific; 3.1.4. Latin America; 3.1.5. Middle East and Africa
4. Price Analysis, 2018 – 2023: 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 – 2023; 4.2. Prominent Factor Affecting Molecular Diagnostics in Infectious Disease Testing Prices; 4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 5.1. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 5.1.1. Key Highlights; 5.1.1.1. Instruments and Analyzers; 5.1.1.2. Assays and Reagents; 5.1.1.3. Services and Software; 5.2. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 5.2.1. Key Highlights; 5.2.1.1. Hepatitis B; 5.2.1.2. Hepatitis C; 5.2.1.3. AIDS; 5.2.1.4. Tuberculosis; 5.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 5.2.1.6. Hospital-Acquired Infections; 5.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 5.2.1.8. Human Papillomavirus (HPV) Infection; 5.2.1.9. Others; 5.3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 5.3.1. Key Highlights; 5.3.1.1. Polymerase Chain Reaction (PCR); 5.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 5.3.1.3. Microarrays; 5.3.1.4. Next-Generation Sequencing (NGS); 5.3.1.5. Hybridization; 5.3.1.6. Others; 5.4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 5.4.1. Key Highlights; 5.4.1.1. Hospitals; 5.4.1.2. Private Labs; 5.4.1.3. Clinics; 5.4.1.4. Academic Institutes; 5.4.1.5. Laboratories; 5.4.1.6. Others; 5.5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 5.5.1. Key Highlights; 5.5.1.1. North America; 5.5.1.2. Europe; 5.5.1.3. Asia Pacific; 5.5.1.4. Latin America; 5.5.1.5. Middle East & Africa
6. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 6.1. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.1.1. Key Highlights; 6.1.1.1. Instruments and Analyzers; 6.1.1.2. Assays and Reagents; 6.1.1.3. Services and Software; 6.2. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.2.1. Key Highlights; 6.2.1.1. Hepatitis B; 6.2.1.2. Hepatitis C; 6.2.1.3. AIDS; 6.2.1.4. Tuberculosis; 6.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 6.2.1.6. Hospital-Acquired Infections; 6.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 6.2.1.8. Human Papillomavirus (HPV) Infection; 6.2.1.9. Others; 6.3. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.3.1. Key Highlights; 6.3.1.1. Polymerase Chain Reaction (PCR); 6.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 6.3.1.3. Microarrays; 6.3.1.4. Next-Generation Sequencing (NGS); 6.3.1.5. Hybridization; 6.3.1.6. Others; 6.4. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.4.1. Key Highlights; 6.4.1.1. Hospitals; 6.4.1.2. Private Labs; 6.4.1.3. Clinics; 6.4.1.4. Academic Institutes; 6.4.1.5. Laboratories; 6.4.1.6. Others; 6.5. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1. Key Highlights; 6.5.1.1. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.3. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.4. U.S. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.5. Canada Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.6. Canada Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.7. Canada Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.1.8. Canada Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 7.1. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.1.1. Key Highlights; 7.1.1.1. Instruments and Analyzers; 7.1.1.2. Assays and Reagents; 7.1.1.3. Services and Software; 7.2. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.2.1. Key Highlights; 7.2.1.1. Hepatitis B; 7.2.1.2. Hepatitis C; 7.2.1.3. AIDS; 7.2.1.4. Tuberculosis; 7.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 7.2.1.6. Hospital-Acquired Infections; 7.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 7.2.1.8. Human Papillomavirus (HPV) Infection; 7.2.1.9. Others; 7.3. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.3.1. Key Highlights; 7.3.1.1. Polymerase Chain Reaction (PCR); 7.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 7.3.1.3. Microarrays; 7.3.1.4. Next-Generation Sequencing (NGS); 7.3.1.5. Hybridization; 7.3.1.6. Others; 7.4. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.4.1. Key Highlights; 7.4.1.1. Hospitals; 7.4.1.2. Private Labs; 7.4.1.3. Clinics; 7.4.1.4. Academic Institutes; 7.4.1.5. Laboratories; 7.4.1.6. Others; 7.5. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1. Key Highlights; 7.5.1.1. Germany Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.2. Germany Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.3. Germany Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.4. Germany Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.5. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.6. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.7. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.9. France Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.10. France Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.11. France Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.12. France Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.13. Italy Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.14. Italy Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.15. Italy Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.16. Italy Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.17. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.18. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.19. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.20. Turkey Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.21. Russia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.22. Russia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.23. Russia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.24. Russia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.25. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.26. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.27. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.1.28. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 8.1. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.1.1. Key Highlights; 8.1.1.1. Instruments and Analyzers; 8.1.1.2. Assays and Reagents; 8.1.1.3. Services and Software; 8.2. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.2.1. Key Highlights; 8.2.1.1. Hepatitis B; 8.2.1.2. Hepatitis C; 8.2.1.3. AIDS; 8.2.1.4. Tuberculosis; 8.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 8.2.1.6. Hospital-Acquired Infections; 8.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 8.2.1.8. Human Papillomavirus (HPV) Infection; 8.2.1.9. Others; 8.3. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.3.1. Key Highlights; 8.3.1.1. Polymerase Chain Reaction (PCR); 8.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 8.3.1.3. Microarrays; 8.3.1.4. Next-Generation Sequencing (NGS); 8.3.1.5. Hybridization; 8.3.1.6. Others; 8.4. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.4.1. Key Highlights; 8.4.1.1. Hospitals; 8.4.1.2. Private Labs; 8.4.1.3. Clinics; 8.4.1.4. Academic Institutes; 8.4.1.5. Laboratories; 8.4.1.6. Others; 8.5. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1. Key Highlights; 8.5.1.1. China Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.2. China Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.3. China Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.4. China Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.5. Japan Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.6. Japan Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.7. Japan Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.8. Japan Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.9. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.10. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.11. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.12. South Korea Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.13. India Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.14. India Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.15. India Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.16. India Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.17. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.18. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.19. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.20. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.21. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.22. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.23. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.1.24. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 9.1. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.1.1. Key Highlights; 9.1.1.1. Instruments and Analyzers; 9.1.1.2. Assays and Reagents; 9.1.1.3. Services and Software; 9.2. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.2.1. Key Highlights; 9.2.1.1. Hepatitis B; 9.2.1.2. Hepatitis C; 9.2.1.3. AIDS; 9.2.1.4. Tuberculosis; 9.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 9.2.1.6. Hospital-Acquired Infections; 9.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 9.2.1.8. Human Papillomavirus (HPV) Infection; 9.2.1.9. Others; 9.3. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.3.1. Key Highlights; 9.3.1.1. Polymerase Chain Reaction (PCR); 9.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 9.3.1.3. Microarrays; 9.3.1.4. Next-Generation Sequencing (NGS); 9.3.1.5. Hybridization; 9.3.1.6. Others; 9.4. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.4.1. Key Highlights; 9.4.1.1. Hospitals; 9.4.1.2. Private Labs; 9.4.1.3. Clinics; 9.4.1.4. Academic Institutes; 9.4.1.5. Laboratories; 9.4.1.6. Others; 9.5. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1. Key Highlights; 9.5.1.1. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.2. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.3. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.4. Brazil Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.5. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.6. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.7. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.8. Mexico Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.9. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.10. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.11. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.12. Argentina Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.13. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.14. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.15. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.1.16. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 – 2031: 10.1. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.1.1. Key Highlights; 10.1.1.1. Instruments and Analyzers; 10.1.1.2. Assays and Reagents; 10.1.1.3. Services and Software; 10.2. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.2.1. Key Highlights; 10.2.1.1. Hepatitis B; 10.2.1.2. Hepatitis C; 10.2.1.3. AIDS; 10.2.1.4. Tuberculosis; 10.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA); 10.2.1.6. Hospital-Acquired Infections; 10.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG); 10.2.1.8. Human Papillomavirus (HPV) Infection; 10.2.1.9. Others; 10.3. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.3.1. Key Highlights; 10.3.1.1. Polymerase Chain Reaction (PCR); 10.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT); 10.3.1.3. Microarrays; 10.3.1.4. Next-Generation Sequencing (NGS); 10.3.1.5. Hybridization; 10.3.1.6. Others; 10.4. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.4.1. Key Highlights; 10.4.1.1. Hospitals; 10.4.1.2. Private Labs; 10.4.1.3. Clinics; 10.4.1.4. Academic Institutes; 10.4.1.5. Laboratories; 10.4.1.6. Others; 10.5. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1. Key Highlights; 10.5.1.1. GCC Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.2. GCC Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.3. GCC Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.4. GCC Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.5. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.6. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.7. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.8. South Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.9. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.10. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.11. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.12. Egypt Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.13. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.14. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.15. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.16. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.17. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.18. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.19. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.1.20. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 – 2031; 10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape: 11.1. Technique vs Application Heatmap; 11.2. Company Market Share Analysis, 2023; 11.3. Competitive Dashboard; 11.4. Company Profiles; 11.4.1. Abbott Laboratories; 11.4.1.1. Company Overview; 11.4.1.2. Product Portfolio; 11.4.1.3. Financial Overview; 11.4.1.4. Business Strategies and Development; 11.4.2. Becton; 11.4.2.1. Company Overview; 11.4.2.2. Product Portfolio; 11.4.2.3. Financial Overview; 11.4.2.4. Business Strategies and Development; 11.4.3. Dickinson and Company; 11.4.3.1. Company Overview; 11.4.3.2. Product Portfolio; 11.4.3.3. Financial Overview; 11.4.3.4. Business Strategies and Development; 11.4.4. bioMérieux; 11.4.4.1. Company Overview; 11.4.4.2. Product Portfolio; 11.4.4.3. Financial Overview; 11.4.4.4. Business Strategies and Development; 11.4.5. Thermo Fisher Scientific Inc.; 11.4.5.1. Company Overview; 11.4.5.2. Product Portfolio; 11.4.5.3. Financial Overview; 11.4.5.4. Business Strategies and Development; 11.4.6. F. Hoffmann-La Roche Ltd; 11.4.6.1. Company Overview; 11.4.6.2. Product Portfolio; 11.4.6.3. Financial Overview; 11.4.6.4. Business Strategies and Development; 11.4.7. Siemens AG; 11.4.7.1. Company Overview; 11.4.7.2. Product Portfolio; 11.4.7.3. Financial Overview; 11.4.7.4. Business Strategies and Development; 11.4.8. Veridex, LLC; 11.4.8.1. Company Overview; 11.4.8.2. Product Portfolio; 11.4.8.3. Financial Overview; 11.4.8.4. Business Strategies and Development; 11.4.9. Luminex Corp.; 11.4.9.1. Company Overview; 11.4.9.2. Product Portfolio; 11.4.9.3. Financial Overview; 11.4.9.4. Business Strategies and Development; 11.4.10. GenMark Diagnostics, Inc.; 11.4.10.1. Company Overview; 11.4.10.2. Product Portfolio; 11.4.10.3. Financial Overview; 11.4.10.4. Business Strategies and Development; 11.4.11. Qiagen N.V.; 11.4.11.1. Company Overview; 11.4.11.2. Product Portfolio; 11.4.11.3. Financial Overview; 11.4.11.4. Business Strategies and Development; 11.4.12. Genomix Biotech; 11.4.12.1. Company Overview; 11.4.12.2. Product Portfolio; 11.4.12.3. Financial Overview; 11.4.12.4. Business Strategies and Development; 11.4.13. bioTheranostics; 11.4.13.1. Company Overview; 11.4.13.2. Product Portfolio; 11.4.13.3. Financial Overview; 11.4.13.4. Business Strategies and Development
12. Appendix: 12.1. Research Methodology; 12.2. Report Assumptions; 12.3. Acronyms and Abbreviations

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Pharmaceutical Isolators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Pharmaceutical Isolators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Whey Protein Isolate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Pharmaceutical Excipients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Azelaic Acid Market, By Type (Polymer Grade, Pharma Grade, Technical Grade), By Application (Pharmaceutical, Adhesives, Plastics, Lubricants, Personal Care & Cosmetics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Sodium Sesquicarbonate Market, By Grade (Industrial Grade, Food Grade, and Pharmaceutical Grade), By Application (Detergents & Cleaners, Glass Manufacturing, Water Treatment, Textiles, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Active Pharmaceutical Ingredient Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

HPQ Silica Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Research Assistance

Other tasks